Speakers

Jennifer Elliott is Senior Director of Business Development at Bioptimus, where she drives strategic partnerships that harness AI to transform drug discovery and precision medicine. With more than 20 years of experience spanning biopharma collaborations, companion diagnostics, and translational research, she has built and led multi-million-dollar partnerships that accelerate innovation from biomarker strategy through clinical development and commercialization.

Before joining Bioptimus, Jennifer led oncology and precision diagnostics partnering at QIAGEN, advancing collaborations across oncology and immune-mediated disease, and held senior business development roles at Epic Sciences supporting cutting-edge cancer programs. She holds a BS in Biology and Spanish and a PhD in Drug Discovery and Bioinformatics from Brandeis University.

Jennifer is passionate about connecting science, technology, and industry to unlock the next generation of AI-powered healthcare breakthroughs.